Quantcast

Lipitor Lawsuit News: JPML Receives Second Request for Consolidated Lipitor Litigation For Claims Alleging the Drug Caused Diabetes, Bernstein Liebhard LLP Reports

October 15, 2013

The Firm is investigating Lipitor lawsuits on behalf of patients who developed Type 2 diabetes, allegedly due to their use of Lipitor.

New York, New York (PRWEB) October 15, 2013

Lipitor lawsuits (http://www.thelipitorlawsuit.com/) continue to mount in courts around the country, prompting a plaintiff who allegedly developed Type 2 diabetes from their use of the statin to file a second motion seeking the establishment of a multidistrict litigation for all federally-filed Lipitor claims, Bernstein Liebhard LLP reports. According to the new Motion, which was filed with the U.S. Judicial Panel on Multidistrict Litigation (JPML) on October 10th, there are now 62 Lipitor lawsuits pending in 21 federal courts. Plaintiffs assert that the increase in Lipitor claims should prompt the Panel to take another look at consolidating the lawsuits in a single federal court for pretrial proceedings. (In re Lipitor (Atorvastatin) Litigation, MDL No. 2502 (JPML))

“Our Firm expects many more Lipitor lawsuit filings, as we continue to hear from patients who developed Type 2 diabetes, allegedly due to this statin. A consolidated proceeding like the one being requested would provide an efficient means of litigating these claims,” says Bernstein Liebhard LLP, a nationwide law firm representing victims of defective drugs and medical devices. The Firm is currently offering free Lipitor lawsuit consultations to anyone who may have been harmed by this medication.

Lipitor and Diabetes

According to court documents, plaintiffs in Lipitor lawsuits had requested the consolidation of these claims earlier this year. But the JPML had denied this request, stating that there were not enough lawsuits to justify the creation of a multidistrict litigation. At the time the request was denied, just 24 Lipitor lawsuits involving diabetes allegations had been filed in federal courts around the country. The new Motion for a multidistrict litigation proposes that the proceeding be established in U.S. District Court, District of South Carolina, where 14 Lipitor lawsuits have already been filed and are being coordinated in an informal manner.

Court records also indicate that a number of similar Lipitor lawsuits have also been consolidated in U.S. District Court, Southern District of Illinois, for the purposes of discovery and other pretrial proceedings. (Hines v.Pfizer Inc., No. 13-404, S.D. Ill.)

The Lipitor litigation has been growing since February 2012, when the U.S. Food & Drug Administration (FDA) ordered Pfizer, Inc. to add new warnings to the Lipitor label regarding an increased risk of new-onset diabetes in patients who took the cholesterol-lowering statin. The label modifications were ordered after research that appeared in JAMA: Internal Medicine reported that post-menopausal women treated with drugs like Lipitor were more likely to develop the disease.*

In May 2013, the British Medical Journal also reported an association between Lipitor and diabetes, finding that patients who took the drug had a 22 percent increased risk of new-onset diabetes.**

Individuals who developed Type 2 diabetes allegedly due to Lipitor may want to consider filing a Lipitor lawsuit to obtain compensation for their medical bills, lost wages, and other injury-related damages. Learn More about potential Lipitor side effects at Bernstein Liebhard LLP’s website. To arrange for a free case review, please call 800-511-5092.

*archinte.jamanetwork.com/article.aspx?articleid=1108676, JAMA Internal Medicine, January 2012

**bmj.com/content/346/bmj.f2610, BMJ, May 2013

About Bernstein Liebhard LLP

Bernstein Liebhard LLP is a New York-based law firm exclusively representing injured persons in complex individual and class action lawsuits nationwide since 1993, including those who have been harmed by dangerous drugs, defective medical devices and consumer products. The firm has been named by The National Law Journal to the “Plaintiffs’ Hot List,” recognizing the top plaintiffs’ firms in the country, for the past 10 consecutive years.

Bernstein Liebhard LLP

10 East 40th Street

New York, New York 10016

800-511-5092

ATTORNEY ADVERTISING. © 2013 Bernstein Liebhard LLP. The law firm responsible for this advertisement is Bernstein Liebhard LLP, 10 East 40th Street, New York, New York 10016, 800-511-5092. Prior results do not guarantee or predict a similar outcome with respect to any future matter.

Contact Information:

Felecia L. Stern, Esq.

Bernstein Liebhard LLP

info (at) consumerinjurylawyers (dot) com

http://www.thelipitorlawsuit.com/

For the original version on PRWeb visit: http://www.prweb.com/releases/lipitor-lawsuit/lipitor-diabetes/prweb11233151.htm


Source: prweb



comments powered by Disqus